The following types of proposals will be reviewed for feasibility prior to study intake. Please review the steps to submitting a feasibility intake form.
Industry-Sponsored Clinical Research Studies
Beginning September 1, 2022, all new industry-sponsored clinical research studies, will be reviewed for feasibility by the Miller School of Medicine (MSOM) Research Feasibility Committee (RFC) prior to IRB submission.
This process will optimize the allocation of institutional resources and effort, while improving the overall performance of clinical research at the Miller School of Medicine.
What do I need to do?
Study teams will be required to complete the Feasibility Intake Form for all new, industry-sponsored clinical research studies, prior to IRB submission and ORA contracting.
Who do I contact with questions?
If you have any questions, please feel free to contact the Committee at email@example.com.
Research Committee Process and Timeline
Videos on Research Feasibility Assessment Tools
For more information, including training videos on how to perform a feasibility check/query/analysis using programs like URIDE or Epic SlicerDicer, click on the link for the Research Feasibility Assessment Tools. First time users will need to register for an account with your University of Miami email address. Once registered and/or logged in, click “Enroll Me” to view the video and PowerPoint training materials for how to use these feasibility tools.
|Maria L. Alcaide, MD (Chair)||Medicine/Infectious Diseases|
|Carl Schulman, MD, PhD (Co-Chair)||Surgery/Burn|
|Maria T. Abreu, MD||Medicine/Gastroenterology|
|Barbara J. Coffey, MD||Psychiatry|
|Stephen D. Nimer, MD||Hematology|
|Patrizio Pasquale, MD||Obstetrics and Gynecology|
|Vittorio Porciatti, DSc||Ophthalmology|
|JoNell E. Potter, PhD||Obstetrics and Gynecology/Reproductive Sciences|
|Sanoj Punnen, MD||Urology|
|David Reis, PhD||UHealth IT|
All investigators interested in conducting a COVID-19 related study must complete the COVID-19 study intake form before submitting the study to the HSRO and ORA.
The Feasibility Committee is made up of scientific and clinical experts at the Miller School of Medicine. The committee’s charge is to assess which studies have the best chance of benefiting current and future patients with the goal of improving the quality of research and to ensure that there are not duplicative studies with the same participant population. Investigators will be notified of the Committee’s decision and recommendation.
If you have any questions regarding the new COVID-19 Feasibility Committee, please email firstname.lastname@example.org.
The Office of the Executive Dean for Research and Miami CTSI support this schoolwide COVID-19 Feasibility Committee led by Maria Abreu, M.D., Vice Chair for Research in the Department of Medicine.
|Maria Abreu, MD (CHAIR)||Medicine/Gastroenterology|
|Jose Castro, MD||Medicine/Infectious Diseases|
|Susanne Doblecki-Lewis, MD||Medicine/Infectious Diseases|
|Elizabeth Franzmann, MD||Otolaryngology/Head and Neck|
|Hayley Gershengorn, MD||Medicine/Pulmonary|
|Richard A. Preston, MD||Medicine/Clinical Pharmacology|
|Richard Silverman, MD||Anesthesiology/Critical Care Medicine|
|Adam Wanner, MD||Medicine/Pulmonary|